https://www.ncbi.nlm.nih.gov › pubmed
by G Ristori - 1999 - Cited by 79 - Related articles
Neurology. 1999 Oct 22;53(7):1588-9. Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis. Ristori G(1 ), Buzzi MG, Sabatini U, Giugni E, Bastianello S, Viselli F, Buttinelli C, Ruggieri S, Colonnese ...
MS Discovery Forum › ... › New Findings
Dec 6, 2013 - In the study, published December 4, 2013, in Neurology (Ristori et al.) .... It could take years for BCG vaccine to become a standard treatment against MS, Ristori told MSDF, but he imagines BCG ...
multiple-sclerosis-research.blogspot.com › ...
Dec 13, 2013 - Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, ... OBJECTIVE:To evaluate Bacille Calmette-Guérin (BCG) effects after clinically isolated syndromes ...
Neurology › content
by G Ristori - 1999 - Cited by 79 - Related articles
Use of Bacille Calmette–Guèrin (BCG) in multiple sclerosis. G. Ristori, PhD,; M.G Buzzi, MD,; U. Sabatini, PhD,; E. Giugni, MD,; S. Bastianello, MD,; F. Viselli, MD,; C. Buttinelli, MD,; S. Ruggieri, MD ...
This is MS › ... › General Discussion
Nov 7, 2016 - 4 posts - 3 authors
BCG has been used for over 80 years worldwide as a vaccine for tuberculosis (TB) and is also used for the ... Led by Dr. Giovani Ristori at Sapienza University in Rome and supported by the Multiple ...
Nature Journal › nrneurol.2013.272.pdf
Jan 7, 2014 - Original article Ristori, G. et al. Effects of Bacille Calmette–Guerin after the first demyelinating ... who were vaccinated with BCG had significantly reduced disease activity on MRI and reduced risk.
Facebook › BCGautoimmunity › posts
Coverage of Dr. Ristori and colleagues' trial using the BCG vaccine in multiple sclerosis: http://www.bbc.co. uk/news/health-25207033.
Elsevier › pure › sapienza › publications
by G Ristori - 1999 - Cited by 82 - Related articles
Oct 22, 1999 - G. Ristori ; M. G. Buzzi ; U. Sabatini ; E. Giugni ; S. Bastianello ; F. Viselli ; C. Buttinelli ; S. Ruggieri ... We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an ...
ClinicalTrials.gov › show › NCT00202410
Sep 12, 2005 - Official Title: Phase 2-3 Use of Bacille Calmette-Guèrin (BCG) Vaccine in Patients With a First Clinical Demyelinating ... Principal Investigator: Giovanni Ristori, MD, University of Roma La Sapienza ...
https://books.google.com › books
Denise Faustman - 2014 - Medical
Dr. Karaci's data shows that multiple doses of BCG, with the first dose in the neonatal period, are most ... Ristori, an expert on multiple sclerosis (MS), opened his talk with the historical point that the use of BCG or ...
No comments:
Post a Comment